C
CBDN
vs
S
S&P TSX Composite Index (Canada)
Over the past 12 months, CBDN has underperformed S&P TSX Composite Index (Canada), delivering a return of 0% compared to the S&P TSX Composite Index (Canada)'s +31% growth.
Stocks Performance
CBDN vs S&P TSX Composite Index (Canada)
Performance Gap
CBDN vs S&P TSX Composite Index (Canada)
Performance By Year
CBDN vs S&P TSX Composite Index (Canada)
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Cbd Global Sciences Inc
Glance View
Cbd Global Sciences, Inc. engages in business of producing and selling industrial hemp derived cannabidiol infused consumable and topical products. The company is headquartered in Calgary, Alberta. The company went IPO on 2019-10-29. The firm is engaged in the business of producing and selling industrial hemp derived CBD infused consumable and topical products, including but not limited to CBD oil tincture drops, CBD hydration beverages, and CBD topicals. The company markets and sells its own brand of CBD oil and byproducts under the Aethics and CannaOil brands (Products), which includes CBD Oil tinctures (liquid products), CBD capsules, CBD topicals, hydration products and confectionary products. Its hemp-derived CBD extracts are sold through distributors, brick and mortar retailers and online. The Company, through its wholly owned subsidiaries, Global Sciences Holdings, Resinosa LLC and Legacy Distribution Group, is delivering CBD products both in a retail and e-commerce formats. Its subsidiaries include Strasburg Pharms, LLC, Global NV Corp., CannaOil, Inc., SMBT, LLC, Global Sciences IP, LLC and Energy Unleased LLC, among others.
